Jill P Buyon MD

Rheumatology•New York, NY

Professor of Medicine, NYU School of Medicine

Join to View Full Profile

333 E 38th St# NyuNew York, NY 10016
Phone+1 646-501-7400
Fax+1 646-501-7228

Education & Training

NYU Grossman School of MedicineFellowship, Rheumatology, 1981 - 1983
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1978 - 1981
Albert Einstein College of MedicineClass of 1978

Certifications & Licensure

NJ State Medical License 1982 - Present
NY State Medical License 1979 - 2026
FL State Medical License 2016 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014
Top Doctors: New York Metro Area Castle Connolly, 2002-2014
New York Magazine: Top Doctors Castle Connolly, 2002-2008, 2010-2014
Super Doctor SuperDoctors.com
Fellow (FACR) American College of Rheumatology
Join now to see all

Clinical Trials

Safety of Estrogens in Lupus: Hormone Replacement Therapy Start of enrollment: 1996 Apr 01
Terminated
Phase 3
Safety of Estrogens in Lupus: Birth Control Pills Start of enrollment: 1997 Jun 01
Completed
Phase 3
Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus Start of enrollment: 2000 Oct 01
Completed
Not Applicable
The Research Registry for Neonatal Lupus Start of enrollment: 2010 May 27
Completed
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS) Start of enrollment: 2003 Sep 01
Recruiting
Preventive IVIG Therapy for Congenital Heart Block Start of enrollment: 2007 Apr 01
Completed
Early Phase 1
Preventive Approach to Congenital Heart Block With Hydroxychloroquine Start of enrollment: 2011 Jan 01
Completed
Phase 2
International Prospective Study on Adherence to Treatment in Patients With Active Systemic Lupus Erythematosus Start of enrollment: 2013 Jan 01
Completed
Rituximab and Belimumab for Lupus Nephritis Start of enrollment: 2015 Jul 09
Completed
Phase 2
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ) Start of enrollment: 2020 Aug 01
Recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

2 citations
Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network.
Philip M Carlucci, Katherine Preisinger, Kristina K Deonaraine, Devyn Zaminski, Maria Dall'Era
Rheumatology. 2025-03-01
Low versus high initial oral glucocorticoid dose for lupus nephritis: a pooled analysis of randomised controlled clinical trials.
Amit Saxena, Cristina Sorrento, Peter Izmirly, Janine Sullivan, Monica Gamez-Perez
Lupus Science & Medicine. 2025-01-06
Substantiation of trophoblast transport of maternal anti-SSA/Ro autoantibodies in fetuses with rapidly progressive cardiac injury: implications for neonatal Fc recepto...
Jill P Buyon, Philip M Carlucci, Bettina F Cuneo, Mala Masson, Peter Izmirly
The Lancet. Rheumatology. 2025-01-01

Journal Articles

The Prevention, Screening and Treatment of Congenital Heart Block from Neonatal Lupus: A Survey of Provider Practices
Matthew R Williams, Eliza Chakravarty, Lisa R Sammaritano, Jill Buyon, Bonnie Bermas, Rheumatology
A Prospective International Study on Adherence to Treatment in 305 Patients with Flaring SLE: Assessment by Drug Levels and Self‐Administered Questionnaires
Peter Izmirly, Michelle Petri, Meenakshi Jolly, Jill Buyon, Clinical Pharmacology & Therapeutics

Lectures

CME Event - Clinical Advances in Lupus
Association of Black Cardiologists,Inc. (ABC), Detroit, Michigan - 4/13/2013
CME Event - Clinical Advances in Lupus
Association of Black Cardiologists,Inc. (ABC), Cincinnati, Ohio - 4/6/2013

Other

Tubulointerstitial Damage in Lupus Nephritis: A Comparison of the Factors Associated with Tubulointerstitial Inflammation and Renal Scarring
Jill Buyon, MD, Arthritis & Rheumatology
https://www.doximity.com/articles/17ea5c20-c7ef-4590-8eb8-a8d805417b8d
UpToDate, Wolters Kluwer Health - 2012-09-21

Press Mentions

Lupus Linked with Greater Risk of Cardiovascular Complications of ChildbirthNovember 29th, 2022
In Small Study, CAR-T Therapy Pushes Lupus into RemissionSeptember 15th, 2022
People with Lupus Benefit from COVID-19 Vaccine BoosterJuly 12th, 2022
Join now to see all

Grant Support

Digital Pathology and Computational Image Analysis for Lupus NephritisUNIVERSITY OF MICHIGAN AT ANN ARBOR2024–2029
Mechanisms of DNA-Specific Autoimmunity in Systemic Lupus ErythematosusNEW YORK UNIVERSITY SCHOOL OF MEDICINE2018–2029
Stopping Hydroxychloroquine In Elderly Lupus Disease (SHIELD)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2023–2028
Stopping Hydroxychloroquine In Elderly Lupus Disease (SHIELD)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2023–2028
Stopping Hydroxychloroquine In Elderly Lupus Disease (SHIELD)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2023–2028
Stopping Hydroxychloroquine In Elderly Lupus Disease (SHIELD)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2023–2028
DP22-002 HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and HealthNEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2027
DP22-002 HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and HealthNEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2027
DP22-002 HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and HealthNEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2027
DP22-002 HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and HealthNEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2027
DP22-002 HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and HealthNEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2027
DP22-002 HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and HealthNEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2027
DP22-002 HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and HealthNEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2027
DP22-002 HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and HealthNEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2027
Translational Basic and Clinical Research Training in RheumatologyNEW YORK UNIVERSITY SCHOOL OF MEDICINE2017–2027
Translational Basic and Clinical Research Training in RheumatologyNEW YORK UNIVERSITY SCHOOL OF MEDICINE2017–2027
Translational Basic and Clinical Research Training in RheumatologyNEW YORK UNIVERSITY SCHOOL OF MEDICINE2017–2027
Translational Basic and Clinical Research Training in RheumatologyNEW YORK UNIVERSITY SCHOOL OF MEDICINE2017–2027
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2026
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2026
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2020–2025
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2020–2025
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2020–2025
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2020–2025
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2020–2025
Preventive Approach To Congenital Heart Block With Hydroxychloroquine (PATCH)Eunice Kennedy Shriver National Institute Of Child Health &Human Development2012
Maternal Autoantibodies: Pathogenesis Of Neonatal LupusNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008–2012
Research Registry For Neonatal LupusNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010
Research Registry For Neonatal LupusNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2009
Preventative IVIG Therapy For Congenital Heart Block (PITCH)National Center For Research Resources2008
Predictors Of Pregnancy Outcomes In SLE And APSNational Center For Research Resources2004–2008
ACR Re-Classification Of SLE Criteria (A Rose)National Center For Research Resources2007
Maternal Autoantibodies: Pathogenesis Of Neonatal LupusNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006–2007
Understanding The Selena Trial: Estrogen In LupusNational Center For Research Resources2006
Maternal Autoantibodies: Pathogenesis Of Neonatal LupusNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004–2005
Safety Of Estrogen In Lupus ErythematosusNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2001–2004
Study Of Dexamethasone In Neonatal Lupus ChbNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2000–2004
Maternal Autoantibodies--Pathogenesis Of Neonatal LupusNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1994–2003
Safety Of Estrogen In Lupus Erythematosus--National AssessmentNational Center For Research Resources2000
Safety Of Estrogen In Lupus Erythematosus- Nat'L Assess'National Institute Of Arthritis And Musculoskeletal And Skin Diseases1996–2000
Research Registry For Neonatal LupusNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1994–2000
Oral Contraceptives And Hormonal Replacement In SLENational Institute Of Arthritis And Musculoskeletal And Skin Diseases1995
International Conference On Rheumatic Diseases PregnancyNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1992